When gated by the expression of CD11c and MHC Ihi, the percentages of CD86+MHC IIhi DCs in tumor-associated draining lymph nodes of mice treated with various protocols did not show differences (p = 0.14, Figure 7F). This evidence concerns the gene ITGAX and neoplasm.